Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Other Non Operating Income (2020 - 2025)

Bioventus' Other Non Operating Income history spans 6 years, with the latest figure at -$1.1 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 179.21% year-over-year to -$1.1 million; the TTM value through Dec 2025 reached -$2.5 million, changed N/A, while the annual FY2025 figure was -$1.5 million, N/A changed from the prior year.
  • Other Non Operating Income reached -$1.1 million in Q4 2025 per BVS's latest filing, down from -$79000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.6 million in Q2 2023 to a low of -$9.4 million in Q4 2022.
  • Average Other Non Operating Income over 5 years is -$624300.0, with a median of -$411500.0 recorded in 2021.
  • Peak YoY movement for Other Non Operating Income: surged 1325.23% in 2021, then crashed 1133.33% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $1.4 million in 2021, then tumbled by 792.21% to -$9.4 million in 2022, then surged by 107.53% to $709000.0 in 2023, then crashed by 156.98% to -$404000.0 in 2024, then plummeted by 179.21% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Other Non Operating Income are -$1.1 million (Q4 2025), -$79000.0 (Q3 2025), and -$561000.0 (Q2 2025).